Testing for Occult Cancer in Patients with Idiopathic Deep Vein Thrombosis – A Decision Analysis
暂无分享,去创建一个
[1] L. Salleras,et al. Cost-Effectiveness of Breast Cancer Screening in Spain , 1996, International Journal of Technology Assessment in Health Care.
[2] E. Cook,et al. Importance of Findings on the Initial Evaluation for Cancer in Patients with Symptomatic Idiopathic Deep Venous Thrombosis , 1996, Annals of Internal Medicine.
[3] M. Weinstein,et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.
[4] E. Bastounis,et al. The incidence of occult cancer in patients with deep venous thrombosis: a prospective study , 1996, Journal of internal medicine.
[5] L. Tabár,et al. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. , 1995, Statistics in medicine.
[6] B. Littenberg. A Practice Guideline Revisited: Screening for Hypertension , 1995, Annals of Internal Medicine.
[7] C. Gilks,et al. Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice: a prospective study. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[8] S. Moss,et al. Effect of Retesting with Dietary Restriction in Haemoccult Screening for Colorectal Cancer , 1995, Journal of medical screening.
[9] L. Tabár,et al. Effect of Breast Cancer Screening after Age 65 , 1995, Journal of medical screening.
[10] J. Austoker,et al. Revision of “NHS Breast Screening: The Facts”: An Evaluation , 1995, Journal of medical screening.
[11] E. Messing,et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. , 1995, Urology.
[12] M. Stampfer,et al. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.
[13] S G Pauker,et al. Screening for prostate cancer. A decision analytic view. , 1994, JAMA.
[14] J. O'Meara,et al. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. , 1994, The New England journal of medicine.
[15] H. Glick,et al. Cost-effectiveness Analysis of Strategies for Colorectal Cancer Screening in Japan , 1994, International Journal of Technology Assessment in Health Care.
[16] T. Kjellstrom,et al. Deep venous thrombosis and occult malignancy: an epidemiological study , 1994, BMJ.
[17] G. H. Nelson,et al. Comparison of transvaginal sonography with endometrial biopsy in asymptomatic postmenopausal women. , 1994, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[18] V. Dorr,et al. An evaluation of prostate-specific antigen as a screening test for prostate cancer. , 1993, Archives of internal medicine.
[19] R. Kane,et al. Characteristics of prostate cancers detected in a multimodality early detection program , 1993 .
[20] D B Matchar,et al. The Effectiveness of Ovarian Cancer Screening: A Decision Analysis Model , 1993, Annals of Internal Medicine.
[21] L M Schuman,et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.
[22] M. Monreal,et al. Occult cancer in patients with acute pulmonary embolism. A prospective study. , 1993, Chest.
[23] M. Prins,et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. , 1992, The New England journal of medicine.
[24] L. Tabár,et al. Breast screening, prognostic factors and survival--results from the Swedish two county study. , 1991, British Journal of Cancer.
[25] J Drago,et al. The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men , 1991, Cancer.
[26] M. Monreal,et al. Occult cancer in patients with deep venous thrombosis. A systematic approach , 1991, Cancer.
[27] R. Lew,et al. Advances in screening protocols for the detection of early bladder cancer. , 1990, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[28] M. Monreal,et al. Cancer and deep venous thrombosis. , 1988, Archives of internal medicine.
[29] L. Tabár,et al. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. , 1987, British Journal of Cancer.
[30] J. Gore,et al. Occult malignant neoplasm in patients with deep venous thrombosis. , 1987, Archives of internal medicine.
[31] L. Kessler,et al. The prevalence of cancer. Estimates based on the Connecticut Tumor Registry. , 1986, The New England journal of medicine.
[32] M Moskowitz,et al. Breast cancer: age-specific growth rates and screening strategies. , 1986, Radiology.
[33] A. Zelikovski,et al. Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer , 1986, Cancer.
[34] W. Odling-Smee,et al. Screening for Breast Cancer , 1985, The Lancet.
[35] S D Walter,et al. Estimation of the duration of a pre-clinical disease state using screening data. , 1983, American journal of epidemiology.
[36] J. Gore,et al. Occult cancer in patients with acute pulmonary embolism. , 1982, Annals of Internal Medicine.
[37] J. Kassirer,et al. The threshold approach to clinical decision making. , 1980, The New England journal of medicine.
[38] C Milligan,et al. Screening for cervical cancer. , 1975, The American journal of nursing.
[39] M Zelen,et al. Some pitfalls in the evaluation of screening programs. , 1969, Archives of environmental health.
[40] M. Melamed,et al. Further cytologic and histologic studies of bladder lesions in workers exposed to para-aminodiphenyl: progress report. , 1969, Journal of the National Cancer Institute.
[41] S. Ferrero,et al. Diagnostic methods of early detection of endometrial hyperplasia and cancer. , 1995, European journal of gynaecological oncology.
[42] J. Hiller,et al. Screening for Colorectal Cancer: What are the Costs? , 1995, International Journal of Technology Assessment in Health Care.
[43] N. Umesaki,et al. Comparison between transabdominal and transvaginal ultrasonography for identifying endometrial malignancies. , 1995, Gynecologic and obstetric investigation.
[44] D A Redelmeier,et al. Screening for colorectal cancer. , 1995, The New England journal of medicine.
[45] J. Tabernero,et al. Endometrial cancer stages I and II. Analysis of survival and prognostic factors. , 1995, European journal of gynaecological oncology.
[46] T. Tong,et al. Cancer statistics, 1994 , 1994, CA: a cancer journal for clinicians.
[47] Jerome P. Kassirer,et al. A Convenient Approximation of Life Expectancy , 1992 .
[48] G. Farrow. Pathologist's role in bladder cancer. , 1979, Seminars in oncology.